These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25217059)

  • 21. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
    Gierthmühlen J; Arning P; Binder A; Herzog J; Deuschl G; Wasner G; Baron R
    Mov Disord; 2010 Jul; 25(9):1195-202. PubMed ID: 20629160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.
    Witjas T; Kaphan E; Régis J; Jouve E; Chérif AA; Péragut JC; Azulay JP
    Mov Disord; 2007 Sep; 22(12):1729-34. PubMed ID: 17557355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update of the impact of deep brain stimulation on non motor symptoms in Parkinson's disease.
    Klingelhoefer L; Samuel M; Chaudhuri KR; Ashkan K
    J Parkinsons Dis; 2014; 4(2):289-300. PubMed ID: 24613865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.
    Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
    Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
    Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Chou KL; Persad CC; Patil PG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
    Siderowf A; Jaggi JL; Xie SX; Loveland-Jones C; Leng L; Hurtig H; Colcher A; Stern M; Chou KL; Liang G; Maccarone H; Simuni T; Baltuch G
    Mov Disord; 2006 Jun; 21(6):746-53. PubMed ID: 16463342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Subthalamic Stimulation on Olfactory Function in Parkinson Disease.
    Cury RG; Carvalho MJ; Lasteros FJL; Dias AE; Dos Santos Ghilardi MG; Paiva ARB; Coutinho AM; Buchpiguel CA; Teixeira MJ; Barbosa ER; Fonoff ET
    World Neurosurg; 2018 Jun; 114():e559-e564. PubMed ID: 29548954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.